| Literature DB >> 22284142 |
Misha M Heller1, Jillian W Wong, Tien V Nguyen, Eric S Lee, Tina Bhutani, Alan Menter, John Y M Koo.
Abstract
The negative impact of psoriasis on a patient's quality of life (QoL) is well documented in the literature. Patients often suffer poor self-esteem, difficulties in social interactions, and significant psychological distress. It is, therefore, critically important that a clinician evaluate the extent to which the disease impacts a patient's QoL. This chapter reviews several validated and reliable generic, dermatology-specific, and disease-specific QoL instruments useful in measuring the impact of psoriasis on patient's QoL. These QoL instruments can be especially helpful in identifying those patients who would most benefit from systemic or biologic therapy.Entities:
Mesh:
Year: 2012 PMID: 22284142 DOI: 10.1016/j.det.2011.11.006
Source DB: PubMed Journal: Dermatol Clin ISSN: 0733-8635 Impact factor: 3.478